Cargando…

Hypermethylated KLF9 Is An Independent Prognostic Factor For Favorable Outcome In Breast Cancer

BACKGROUND AND OBJECTIVE: Breast cancer (BC) is the most lethal human malignancy and is the leading cause of cancer-associated death in women worldwide. Krüppel-like factor 9 (KLF9) belongs to a family of transcriptional regulators and its role in BC has not been fully investigated. METHOD: Data min...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei, Mao, Qiqi, Zhou, Shaocheng, Ji, Xiaochun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874775/ https://www.ncbi.nlm.nih.gov/pubmed/31819488 http://dx.doi.org/10.2147/OTT.S226121

Ejemplares similares

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)

DNA hypermethylation of MAL gene may act as an independent predictor of favorable prognosis in patients with colorectal cancer
por: Liu, Xinyan, et al.
Publicado: (2019)

Promoter Hypermethylation of KLF4 Inactivates Its Tumor Suppressor Function in Cervical Carcinogenesis
por: Yang, Wen-Ting, et al.
Publicado: (2014)

Hypermethylation of TRIM59 and KLF14 Influences Cell Death Signaling in Familial Alzheimer's Disease
por: Wezyk, Michalina, et al.
Publicado: (2018)

Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells
por: Guo, Hongshen, et al.
Publicado: (2007)

Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma
por: Kristensen, Lasse Sommer, et al.
Publicado: (2014)

KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro
por: Lin, Lili, et al.
Publicado: (2023)

SOCS3 Promoter Hypermethylation Is a Favorable Prognosticator and a Novel Indicator for G-CIMP-Positive GBM Patients
por: Feng, Ying, et al.
Publicado: (2014)

KLF10 Functions as an Independent Prognosis Factor for Gastric Cancer
por: Lin, Yueh-Min, et al.
Publicado: (2022)

MiR-9 promotes the phenotypic switch of vascular smooth muscle cells by targeting KLF5
por: LU, Xiaochun, et al.
Publicado: (2019)

Downregulation of KLF13 through DNMT1-mediated hypermethylation promotes glioma cell proliferation and invasion
por: Wu, Rile, et al.
Publicado: (2019)

CD8(+ )lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
por: Liu, Shuzhen, et al.
Publicado: (2012)

Krüppel-like factor 9 (KLF9) links hormone dysregulation and circadian disruption to breast cancer pathogenesis
por: Ybañez, Weand S., et al.
Publicado: (2023)

High Myeloperoxidase Positive Cell Infiltration in Colorectal Cancer Is an Independent Favorable Prognostic Factor
por: Droeser, Raoul A., et al.
Publicado: (2013)

Prognostic Relevance of Promoter Hypermethylation of Multiple Genes in Breast Cancer Patients
por: Sharma, Gayatri, et al.
Publicado: (2009)

APC Promoter Hypermethylation as a Prognostic Marker in Breast Cancer Patients
por: Saelee, Pensri, et al.
Publicado: (2020)

High expression of Ki-67 is an independent favorable prognostic factor for esophageal small cell carcinoma
por: Deng, Han-Yu, et al.
Publicado: (2017)

KLF9 and KLF13 transcription factors boost myelin gene expression in oligodendrocytes as partners of SOX10 and MYRF
por: Bernhardt, Celine, et al.
Publicado: (2022)

The Krüppel-like factor 9 (KLF9) network in HEC-1-A endometrial carcinoma cells suggests the carcinogenic potential of dys-regulated KLF9 expression
por: Simmen, Frank A, et al.
Publicado: (2008)

Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer
por: Akhoondi, Shahab, et al.
Publicado: (2010)

Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme
por: Xia, Xiangping, et al.
Publicado: (2019)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

High Expression of KLF10 Is Associated with Favorable Survival in Patients with Oral Squamous Cell Carcinoma
por: Yeh, Chung-Min, et al.
Publicado: (2020)

Predicting 3D Structure, Cross Talks, and Prognostic Significance of KLF9 in Cervical Cancer
por: Safi, Sadia, et al.
Publicado: (2022)

Mammographic casting-type calcification is an independent prognostic factor in invasive breast cancer
por: Li, Yan, et al.
Publicado: (2019)

Prognostic factors for a favorable outcome after varicocele repair in adolescents and adults
por: Samplaski, Mary K, et al.
Publicado: (2016)

Hypermethylated genes as biomarkers of breast cancer
por: Fackler, MJ, et al.
Publicado: (2009)

Prognostic significance of KLF4 in solid tumours: an updated meta-analysis
por: Luo, Xiaoya, et al.
Publicado: (2022)

Intrathecal administration of AYX2 DNA decoy produces a long-term pain treatment in rat models of chronic pain by inhibiting the KLF6, KLF9, and KLF15 transcription factors
por: Mamet, Julien, et al.
Publicado: (2017)

CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma
por: AMATYA, VISHWA JEET, et al.
Publicado: (2012)

Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma
por: Shi, Cheng, et al.
Publicado: (2019)

QPRT Acts as an Independent Prognostic Factor in Invasive Breast Cancer
por: Zhou, Lili, et al.
Publicado: (2022)

MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma
por: Falzone, Luca, et al.
Publicado: (2016)

CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome
por: Li, Mianyang, et al.
Publicado: (2016)

Lack of Ephrin Receptor A1 Is a Favorable Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
por: Toma, Marieta I., et al.
Publicado: (2014)

Hypermethylation of ribosomal DNA in human breast carcinoma
por: Yan, P S, et al.
Publicado: (2000)

The Partial Role of KLF4 and KLF5 in Gastrointestinal Tumors
por: Li, Jun-Chen, et al.
Publicado: (2021)

KLF4α stimulates breast cancer cell proliferation by acting as a KLF4 antagonist
por: Ferralli, Jacqueline, et al.
Publicado: (2016)

Low Expression of APOB mRNA or Its Hypermethylation Predicts Favorable Overall Survival in Patients with Low-Grade Glioma
por: Han, Chong, et al.
Publicado: (2020)

Mechanism of KLF9 in airway inflammation in chronic obstructive pulmonary
por: Gu, Peijie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bhqto7q0li2d0vs5ue00tere4n